Norvegija – Laboratoriniai reagentai – Monitoring of the medicines Adalimumab and Infliximab, tests for concentration in serum to St. Olav Hospital H

Norvegija – Laboratoriniai reagentai – Monitoring of the medicines Adalimumab and Infliximab, tests for concentration in serum to St. Olav Hospital H

I dalis: Perkančioji organizacija

I.1) Pavadinimas ir adresai:

Oficialus pavadinimas: SYKEHUSINNKJØP HF
Adresas: Postboks 40
Miestas: VADSØ
Pašto kodas: 9811
Šalis: Norvegija
Asmuo ryšiams:
El-paštas: post@sykehusinnkjop.no
Interneto adresas (-ai):
Pagrindinis adresas: http://www.sykehusinnkjop.no

II dalis: Objektas

II.1.1) Pavadinimas:

Monitoring of the medicines Adalimumab and Infliximab, tests for concentration in serum to St. Olav Hospital H
Nuorodos numeris: 2024/728

II.1.2) Pagrindinis BVPŽ kodas:

33696500 Kiti vaistai

II.1.3) Sutarties tipas:

Kita

II.1.4) Trumpas aprašymas:

The Department of Immunology and Transfusion Medicine at St.Olavs Hospital uses the above mentioned tests to measure the concentration of the medicines in human serum in patients with autoimmune encephalosis diseases (such as arthritis, Crohn's disease, ulcerative colitis, colorus and multiple sclerosis (MS)). The analyses are part of the disease follow-up, where a monitors medicine concentration.

II.2) Aprašymas:

II.2.1) Kitas (-i) šio pirkimo BVPŽ kodas (-ai):

33690000 Kiti vaistai
33696500 Laboratoriniai reagentai